Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 938

Results For "RI"

10086 News Found

Transforming Healthcare Through AI
Opinion | October 29, 2021

Transforming Healthcare Through AI


Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke
Hospitals | October 29, 2021

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke

It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology


KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals
Hospitals | October 28, 2021

KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals

The combined entity will have 12 hospitals with 3,666 beds


MSD and MPP sign licensing agreement to make molnupiravir affordable
Biotech | October 28, 2021

MSD and MPP sign licensing agreement to make molnupiravir affordable

In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.


Rainbow hospital gives new lease of life to infant on ECMO support
Healthcare | October 28, 2021

Rainbow hospital gives new lease of life to infant on ECMO support

The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease


AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses
Public Health | October 28, 2021

AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses

This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one


Thermo Fisher Scientific unveils Q Digital PCR system
Medical Device | October 28, 2021

Thermo Fisher Scientific unveils Q Digital PCR system

It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development


Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22
News | October 27, 2021

Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22

Cipla has reported consolidated financial results for the period ended September 30, 2021


Torrent Pharma consolidated PAT at Rs 316 cr. in Q2FY22
News | October 27, 2021

Torrent Pharma consolidated PAT at Rs 316 cr. in Q2FY22

Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021


Sanofi India PAT at Rs. 529.8 cr in Q3CY21
News | October 27, 2021

Sanofi India PAT at Rs. 529.8 cr in Q3CY21

The Board of Directors of Sanofi India Limited, at its meeting held on October 26th 2021 have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021